Group 1 - Altria owns Philip Morris USA, the maker of Marlboro cigarettes, and John Middleton, the manufacturer of Black & Mild cigars [1] - The company's smoke-free portfolio includes U.S. Smokeless Tobacco Company, which produces Copenhagen and Skoal, as well as Helix Innovations, known for on! oral nicotine pouches [1]

Core Viewpoint - Altria Group is positioned as a stable investment option during market uncertainty, offering consistent dividend income and potential growth in its smoke-free product segment [2][10]. Financial Performance - Altria's net revenue after excise taxes increased by 1.6% year-over-year to $5.1 billion, despite an 8% decline in cigarette sales volume [3]. - The smokeables division generated an operating income of $10.8 billion in 2024, with a 60% operating margin, highlighting its profitability [3]. Product Strategy - Altria aims to double its smoke-free product sales to $5 billion by 2028, although it currently lags behind competitors like Philip Morris International [4]. - The company is focusing on expanding its smoke-free product offerings, including nicotine pouches and electronic vaping [4]. Capital Returns and Dividends - Altria has reduced its shares outstanding by 14% over the last 10 years, with accelerated buybacks in 2024 [6]. - The dividend per share has increased by approximately 100% over the past decade, with a current quarterly payout of $1.02 [6]. - Management plans to grow the dividend per share at a mid-single-digit percentage rate annually, around 5% through 2028 [7]. Investment Rationale - Investing $1,000 in Altria Group stock is projected to yield around $70 in annual dividend income based on the current yield [9]. - The company has demonstrated a 103% growth in free cash flow per share over the last 10 years, providing a solid foundation for future dividend increases [9][10].

Company Performance - Altria's stock closed at $56.71, reflecting a -1.63% change from the previous day's closing price, underperforming the S&P 500 which gained 0.16% [1] - Over the past month, Altria's shares increased by 4.34%, outperforming the Consumer Staples sector which saw a loss of 0.69% and the S&P 500's loss of 3.59% [2] Upcoming Earnings - Altria is expected to report an EPS of $1.19, representing a 3.48% increase compared to the same quarter last year, with a revenue forecast of $4.66 billion, indicating a 1.11% decrease from the same quarter last year [3] - For the entire fiscal year, earnings are projected at $5.32 per share and revenue at $20.48 billion, reflecting changes of +3.91% and +0.18% respectively from the prior year [4] Analyst Estimates and Rankings - Recent changes in analyst estimates for Altria are crucial as they indicate evolving short-term business trends, with positive revisions suggesting analyst optimism regarding the company's profitability [4] - The Zacks Rank system, which includes estimate changes, currently ranks Altria at 3 (Hold), with the consensus EPS estimate remaining unchanged over the past month [6] Valuation Metrics - Altria has a Forward P/E ratio of 10.84, which is in line with the industry average, and a PEG ratio of 3.07, compared to the tobacco industry average PEG ratio of 2.82 [7] Industry Context - The Tobacco industry, part of the Consumer Staples sector, holds a Zacks Industry Rank of 78, placing it in the top 32% of over 250 industries, indicating strong performance potential [8]